Antimicrobial Agents Practice Questions

Q: Which drug is used for topical application per vaginum?

All of the above. **Explanation:** The correct answer is **D. All of the above**. This question tests the knowledge of topical antifungal therapy for **Vulvovaginal Candidiasis (VVC)**, a common clinical condition caused primarily by *Candida albicans*. **1. Why the correct answer is right:** All three drugs listed belong to classes of antifungals that are poorly absorbed systemically when applied to mucous membranes, making them ideal for local (topical) application. * **Clotrimazole and Miconazole** are **Imidazoles**. They inhibit the enzyme *14-alpha-demethylase*, preventing the synthesis of ergosterol (a key component of the fungal cell membrane). They are available as vaginal creams and pessaries (suppositories). * **Nystatin** is a **Polyene** antibiotic (similar to Amphotericin B). It binds to ergosterol in the fungal cell membrane, creating pores that lead to cell death. It is specifically used for candidal infections and is not absorbed from the skin or vagina. **2. Analysis of Options:** * **Clotrimazole:** Often the first-line topical choice. High-yield fact: It is also used for oropharyngeal candidiasis (troches). * **Miconazole:** Frequently used in over-the-counter vaginal creams and suppositories. * **Nystatin:** While less commonly used now due to the high efficacy of azoles, it remains a classic topical treatment for vaginal thrush. **3. Clinical Pearls for NEET-PG:** * **Drug of Choice:** For VVC, a single dose of **Oral Fluconazole (150 mg)** is often preferred for patient convenience, but topical azoles are equally effective. * **Pregnancy:** Topical imidazoles (like Clotrimazole) are the **preferred treatment** for VVC during pregnancy; oral fluconazole is generally avoided in the first trimester. * **Mechanism Recap:** Azoles = Inhibition of ergosterol *synthesis*; Polyenes = *Binding* to ergosterol.

Q: Which is the safest anti-tuberculosis drug to use during pregnancy?

Isoniazid (INH). **Explanation:** The management of Tuberculosis (TB) during pregnancy follows the standard WHO-recommended regimen, but safety profiles vary among drugs. **Isoniazid (INH)** is considered the safest and most preferred anti-TB drug in pregnancy. It is classified as FDA Category C but has a long-standing record of safety without documented teratogenicity. When administering INH to a pregnant woman, it is mandatory to co-administer **Pyridoxine (Vitamin B6)** to prevent peripheral neuropathy in both the mother and the fetus. **Analysis of Options:** * **Isoniazid (INH):** Correct. It is the cornerstone of TB treatment in pregnancy. While it carries a risk of hepatotoxicity, it does not cause fetal malformations. * **Rifampicin:** Generally considered safe and used in the standard 4-drug regimen (RHE), but it carries a theoretical risk of neonatal hemorrhage due to Vitamin K antagonism. * **Ethambutol:** Considered safe and non-teratogenic; however, INH remains the primary drug of choice for safety profiles in most clinical guidelines. * **Streptomycin:** **Absolutely contraindicated.** It is an aminoglycoside that causes permanent **ototoxicity** (8th cranial nerve damage) and nephrotoxicity in the fetus, leading to congenital deafness. **Clinical Pearls for NEET-PG:** * **Standard Regimen:** The preferred treatment for TB in pregnancy is 2 months of HRZE followed by 4 months of HR. * **Pyrazinamide:** While the WHO recommends its use, some older US guidelines (ATS) traditionally avoided it due to limited safety data; however, it is now widely accepted as safe. * **Contraindicated TB Drugs:** Streptomycin (Ototoxicity) and Ethionamide (Teratogenic). * **Breastfeeding:** All first-line anti-TB drugs (HRZE) are compatible with breastfeeding as they are excreted in negligible amounts in breast milk.

Q: Which of the following is NOT an indication for Metronidazole?

Streptococcal sore throat. **Explanation:** The correct answer is **D. Streptococcal sore throat.** **Mechanism and Spectrum of Action:** Metronidazole is a nitroimidazole derivative that acts by forming reactive cytotoxic intermediates (free radicals) that damage bacterial DNA. This process occurs only under **anaerobic conditions**. Therefore, Metronidazole is highly effective against **obligate anaerobes** and certain **protozoa**, but it has **no activity against aerobic bacteria**. 1. **Streptococcal sore throat (Option D):** This is caused by *Streptococcus pyogenes* (Group A Streptococcus), which is a Gram-positive aerobe/facultative anaerobe. Since Metronidazole lacks activity against aerobic organisms, it is ineffective. The drug of choice for Streptococcal pharyngitis remains Penicillin V or Amoxicillin. **Why other options are incorrect:** * **Ulcerative gingivitis (Option A):** Acute Necrotizing Ulcerative Gingivitis (ANUG) involves anaerobic fusiform bacteria and spirochetes. Metronidazole is a first-line agent here. * **Amoebiasis (Option B):** Metronidazole is the drug of choice for intestinal and extra-intestinal (liver abscess) amoebiasis caused by *Entamoeba histolytica*. * **Trichomonas infection (Option C):** It is the gold standard treatment for *Trichomonas vaginalis* (Trichomoniasis) in both symptomatic patients and their sexual partners. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for:** *Clostridioides difficile* (mild-to-moderate), Bacterial vaginosis, and Giardiasis. * **Disulfiram-like reaction:** Patients must avoid alcohol while on Metronidazole due to the inhibition of aldehyde dehydrogenase. * **Side Effects:** Metallic taste (most common), peripheral neuropathy (prolonged use), and seizures. * **Triple Therapy:** It is a component of the regimen for *H. pylori* eradication.

Q: All of the following are side effects of Linezolid, EXCEPT?

Cardiac arrhythmia. **Explanation:** Linezolid is an oxazolidinone antibiotic used primarily for resistant Gram-positive infections like MRSA and VRE. It acts by inhibiting the formation of the 70S initiation complex. **Why Cardiac Arrhythmia is the correct answer:** Linezolid is **not** associated with cardiac arrhythmias or QT interval prolongation. Its primary toxicities are related to mitochondrial protein synthesis inhibition (due to the similarity between bacterial and mitochondrial ribosomes) and its role as a weak, reversible non-selective Monoamine Oxidase Inhibitor (MAOI). **Analysis of Incorrect Options:** * **Optic Neuropathy:** Prolonged use (usually >28 days) can lead to mitochondrial dysfunction in the optic nerve, resulting in optic neuropathy and potential vision loss. Peripheral neuropathy is also a known risk. * **Pancytopenia:** Linezolid causes time-dependent bone marrow suppression. Thrombocytopenia is the most common manifestation, but it can progress to anemia, leukopenia, and full pancytopenia. Monitoring CBC weekly is recommended. * **Lactic Acidosis:** This is a serious metabolic side effect resulting from Linezolid’s interference with mitochondrial oxidative phosphorylation. **High-Yield Clinical Pearls for NEET-PG:** 1. **Serotonin Syndrome:** Because Linezolid is a weak MAOI, it can cause Serotonin Syndrome if co-administered with SSRIs or other serotonergic drugs. 2. **Mechanism of Action:** Unique binding site on the **23S rRNA of the 50S subunit**, preventing the formation of the 70S initiation complex. 3. **Bioavailability:** It has **100% oral bioavailability**, allowing for an easy IV-to-oral switch. 4. **Drug of Choice:** Often used for Vancomycin-resistant *Enterococcus faecium* (VRE) and Nosocomial pneumonia caused by MRSA.

Q: Which of the following drug classes develops resistance by inactivating enzymes?

All of the above. The primary mechanism of bacterial resistance involves the production of **inactivating enzymes** that chemically modify or destroy the antibiotic before it can reach its target site. 1. **Aminoglycosides:** Resistance most commonly occurs via **group transferases** (enzymes like acetyltransferases, adenyltransferases, and phosphoryltransferases). These enzymes modify the hydroxyl or amino groups of the drug, preventing it from binding to the 30S ribosomal subunit. 2. **Beta-lactams:** The most prevalent mechanism is the production of **Beta-lactamases** (e.g., penicillinase, cephalosporinase, carbapenemase) [1]. These enzymes hydrolyze the cyclic amide bond of the beta-lactam ring, rendering the antibiotic inactive [1, 2]. 3. **Chloramphenicol:** Bacteria produce **Chloramphenicol acetyltransferase (CAT)**. This enzyme acetylates the drug, preventing it from binding to the 50S ribosomal subunit. Since all three classes utilize enzymatic inactivation as a major resistance mechanism, **Option D** is correct. --- ### High-Yield NEET-PG Pearls * **Aminoglycosides:** While enzymatic inactivation is the *most common* mechanism, decreased uptake (porin mutation) is also seen in *Pseudomonas*. * **Beta-lactams:** In *S. aureus* (MRSA), resistance is due to **altered target sites** (PBP2a), not just beta-lactamases. * **Vancomycin:** Resistance occurs via **target site modification** (D-Ala-D-Ala changes to D-Ala-D-Lac). * **Fluoroquinolones:** Resistance primarily occurs through **mutations in DNA gyrase/Topoisomerase IV** and active efflux pumps. * **Tetracyclines:** The most common mechanism is **active efflux** of the drug out of the bacterial cell.

Q: What is the mechanism of action of fluoroquinolones in gram-positive organisms?

Topoisomerase IV. **Explanation:** Fluoroquinolones are bactericidal antibiotics that inhibit bacterial DNA synthesis by targeting two essential enzymes: **DNA gyrase (Topoisomerase II)** and **Topoisomerase IV**. The primary target of fluoroquinolones depends on the type of organism: * **Gram-positive organisms:** The primary target is **Topoisomerase IV**. This enzyme is responsible for the decatenation (separation) of interlinked daughter chromosomes following DNA replication. Inhibition leads to the inability of the bacteria to divide. * **Gram-negative organisms:** The primary target is **DNA gyrase (Topoisomerase II)**, which is responsible for introducing negative supercoils into DNA to relieve torsional strain during replication. **Analysis of Options:** * **Option A & B (DNA gyrase / Topoisomerase II):** These are synonymous in bacteria. While fluoroquinolones do inhibit this enzyme, it is the *primary* target in **Gram-negative** bacteria (e.g., *E. coli*), not Gram-positive ones. * **Option C (Topoisomerase III):** This enzyme is involved in DNA recombination and is not a primary target for fluoroquinolones. * **Option D (Topoisomerase IV):** Correct. In **Gram-positive** bacteria (e.g., *S. pneumoniae*, *S. aureus*), this is the initial and most sensitive target. **High-Yield Clinical Pearls for NEET-PG:** 1. **Resistance Mechanism:** Most commonly occurs via mutations in the **QRDR (Quinolone Resistance-Determining Region)** of the target enzymes or via efflux pumps. 2. **Respiratory Quinolones:** Levofloxacin, Moxifloxacin, and Gemifloxacin are called "respiratory quinolones" due to their enhanced activity against Gram-positive organisms like *S. pneumoniae*. 3. **Contraindications:** Avoid in pregnancy and children (due to potential **cartilage damage/arthropathy**) and in patients with a history of **tendon rupture** or QT prolongation.

Q: All of the following are aminoglycosides except:

Azithromycin. **Explanation:** The correct answer is **Azithromycin** because it belongs to the **Macrolide** class of antibiotics, not Aminoglycosides. **1. Why Azithromycin is the correct answer:** Azithromycin is a broad-spectrum macrolide (along with Erythromycin and Clarithromycin) characterized by a large macrocyclic lactone ring. It acts by binding to the **50S ribosomal subunit**, inhibiting bacterial protein synthesis. It is commonly used for respiratory tract infections, atypical pneumonias, and sexually transmitted infections (Chlamydia). **2. Why the other options are incorrect:** Options A, B, and C are all classic examples of **Aminoglycosides**. Aminoglycosides are characterized by amino sugars linked via glycosidic bonds to a hexose nucleus. They act by binding to the **30S ribosomal subunit**, causing mRNA misreading and inhibition of translocation. * **Streptomycin:** The first aminoglycoside discovered; primarily used today for Tuberculosis (second-line) and Plague. * **Kanamycin:** An older aminoglycoside with significant systemic toxicity, now limited in use. * **Netilmycin:** A semi-synthetic derivative of sisomicin, often resistant to many aminoglycoside-inactivating enzymes. **Clinical Pearls for NEET-PG:** * **Mnemonic for Aminoglycosides:** "STREPT" (Streptomycin, Tobramycin, Gentamicin, Amikacin, Neomycin, Kanamycin, Netilmycin). Note that most end in **"-mycin"** or **"-micin"**. * **Exception Alert:** Do not confuse Macrolides (Erythro**mycin**, Azithro**mycin**) with Aminoglycosides. * **Toxicity:** Aminoglycosides are notorious for **Ototoxicity** (vestibular/cochlear) and **Nephrotoxicity** (Acute Tubular Necrosis). * **Spectrum:** They are bactericidal and primarily effective against **Aerobic Gram-negative bacilli**. They are ineffective against anaerobes because their uptake into the bacteria requires oxygen.

Q: Which drug is an alternative to metronidazole for treating amoebic liver abscess?

Chloroquine. **Chloroquine** is the correct answer because it is a highly effective tissue amoebicide. While Metronidazole (or Tinidazole) remains the drug of choice for amoebic liver abscess (ALA) [1], Chloroquine serves as a potent alternative or adjunct. The pharmacological basis lies in its pharmacokinetics: Chloroquine achieves **very high concentrations in the liver** (several hundred times higher than in plasma), making it lethal to *Entamoeba histolytica* trophozoites residing in hepatic tissue. However, it is ineffective against intestinal amoebiasis as it is rapidly absorbed from the upper GI tract.Analysis of Incorrect Options:* **Ciprofloxacin (A):** This is a fluoroquinolone antibiotic. While it has a broad spectrum against bacteria, it has no significant clinical activity against *E. histolytica*.* **Mebendazole (C):** This is a benzimidazole anthelmintic used primarily for luminal nematodes (like roundworms or whipworms). It acts by inhibiting microtubule synthesis in worms, not protozoa.* **Bephenium Naphthoate (D):** This is an older anthelmintic previously used for hookworm infections. It is not used in the management of amoebiasis.High-Yield Clinical Pearls for NEET-PG:* **Classification:** Amoebicides are divided into **Luminal** (e.g., Diloxanide furoate, Paromomycin, Iodoquinol) and **Tissue** (e.g., Metronidazole, Tinidazole, Chloroquine, Emetine) [1].* **Sequential Therapy:** Treatment of ALA always requires a luminal amoebicide following the tissue amoebicide to eradicate the intestinal reservoir and prevent relapse [1].* **Triple Therapy:** In refractory cases of ALA, a combination of Metronidazole, Chloroquine, and Diloxanide furoate may be used.

Q: Which of the following is NOT true about vancomycin?

Has 95% oral bioavailability. **Explanation:** **1. Why Option A is correct (The Concept):** Vancomycin is a large, complex glycopeptide molecule. Due to its high molecular weight and polar nature, it has **very poor oral bioavailability (<5%)**. It is not absorbed from the gastrointestinal tract into the systemic circulation. Therefore, the statement that it has 95% oral bioavailability is false. **2. Analysis of Incorrect Options:** * **Option B (Inhibits cell wall synthesis):** This is true. Vancomycin inhibits bacterial cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide, preventing cross-linking (transpeptidation). * **Option C (Parenteral and Oral use):** This is true. It is given **IV** for systemic infections (like endocarditis or pneumonia). It is given **orally** specifically for **Clostridioides difficile-associated diarrhea (CDAD)** because it remains in the gut lumen to act locally. * **Option D (Indicated for MRSA):** This is true. Vancomycin is the traditional "gold standard" treatment for Methicillin-resistant *Staphylococcus aureus* (MRSA) infections. **3. High-Yield Clinical Pearls for NEET-PG:** * **Red Man Syndrome:** An infusion-related reaction caused by histamine release; prevented by slowing the infusion rate. * **Spectrum:** Narrow spectrum; active **only** against Gram-positive bacteria. * **Resistance:** Mediated by the replacement of D-Ala-D-Ala with **D-Ala-D-Lac** (seen in VRSA/VRE). * **Adverse Effects:** Ototoxicity and Nephrotoxicity (especially when combined with aminoglycosides). * **Excretion:** Primarily via glomerular filtration; requires dose adjustment in renal failure.

Q: Which of the following groups of antibiotics is used in malaria?

Tetracyclines. **Explanation:** **Why Tetracyclines are the Correct Answer:** Tetracyclines (specifically **Doxycycline** and **Tetracycline**) and the related lincosamide **Clindamycin** possess potent antimalarial activity. They act by targeting the **apicoplast**, a non-photosynthetic plastid organelle in *Plasmodium* species that is essential for parasite survival. By inhibiting protein synthesis within this organelle, these drugs cause a "delayed death" effect, where the parasite survives the first division but fails to survive the second. Due to this slow onset of action, they are never used as monotherapy for acute malaria; instead, they are combined with fast-acting schizonticides like Quinine or Artesunate. **Why Other Options are Incorrect:** * **A. Aminoglycosides:** These inhibit the 30S bacterial ribosome and are primarily used for aerobic Gram-negative infections. They have no clinical role in treating malaria. * **C. Carbapenems:** These are broad-spectrum beta-lactams used for multi-drug resistant bacterial infections (e.g., ESBL producers). They target bacterial cell wall synthesis, which is absent in *Plasmodium*. * **D. Penicillins:** Like carbapenems, these target the peptidoglycan cell wall and are ineffective against protozoal parasites. **High-Yield Clinical Pearls for NEET-PG:** * **Doxycycline** is a first-line agent for **chemoprophylaxis** of malaria in areas with multi-drug resistant *P. falciparum*. * **Clindamycin** is the preferred alternative to Doxycycline for treating malaria in **pregnant women and children** (to avoid tetracycline-induced bone/teeth toxicity). * **Radical cure:** Refers to the eradication of hypnozoites (latent liver stages) of *P. vivax* and *P. ovale*, achieved only by **Primaquine** or **Tafenoquine**.

Question 1

Which drug is used for topical application per vaginum?

Accepted Answer

All of the above

Answer

Clotrimazole

Answer

Miconazole

Answer

Nystatin

Question 2

Which is the safest anti-tuberculosis drug to use during pregnancy?

Accepted Answer

Isoniazid (INH)

Answer

Rifampicin

Answer

Ethambutol

Answer

Streptomycin

Question 3

Which of the following is NOT an indication for Metronidazole?

Accepted Answer

Streptococcal sore throat

Answer

Ulcerative gingivitis

Answer

Amoebiasis

Answer

Trichomonas infection

Question 4

All of the following are side effects of Linezolid, EXCEPT?

Accepted Answer

Cardiac arrhythmia

Answer

Optic neuropathy

Answer

Pancytopenia

Answer

Lactic acidosis

Question 5

Which of the following drug classes develops resistance by inactivating enzymes?

Accepted Answer

All of the above

Answer

Aminoglycosides

Answer

Beta lactams

Answer

Chloramphenicol

Question 6

What is the mechanism of action of fluoroquinolones in gram-positive organisms?

Accepted Answer

Topoisomerase IV

Answer

DNA gyrase

Answer

Topoisomerase II

Answer

Topoisomerase III

Question 7

All of the following are aminoglycosides except:

Accepted Answer

Azithromycin

Answer

Netilmycin

Answer

Streptomycin

Answer

Kanamycin

Question 8

Which drug is an alternative to metronidazole for treating amoebic liver abscess?

Accepted Answer

Chloroquine

Answer

Ciprofloxacin

Answer

Mebendazole

Answer

Bephenium Naphthoate

Question 9

Which of the following is NOT true about vancomycin?

Accepted Answer

Has 95% oral bioavailability

Answer

Inhibits cell wall synthesis

Answer

Can be used parenterally as well as orally

Answer

Is indicated for MRSA infections

Question 10

Which of the following groups of antibiotics is used in malaria?

Accepted Answer

Tetracyclines

Answer

Aminoglycosides

Answer

Carbapenems

Answer

Penicillins

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?